Fiduciary Trust’s Teladoc Health TDOC Stock Holding History

Fiduciary Trust’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,225	Closed	-$405K	–	644
2021 Q1	$405K	Buy	+2,225	New	+$516K	0.01%	484

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fiduciary Trust's TDOC Position: Q2 2021 in Review

Fiduciary Trust sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 2,225 shares — an estimated $405K sold.

Fiduciary Trust first reported a position in TDOC in Q1 2021 and held it in 1 quarter. The position peaked at $405K in Q1 2021. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

Fiduciary Trust reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
Fiduciary Trust sold 2,225 Teladoc Health shares in Q2 2021, an estimated $405K.
Fiduciary Trust first reported a position in Teladoc Health in Q1 2021 and held it in 1 quarter.
Fiduciary Trust's Teladoc Health position peaked at $405K in Q1 2021.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on Fiduciary Trust's 13F filing for Q2 2021, filed 16 Aug 2021.